Stockreport

AbbVie Sees Signs of Post-Humira Growth in Positive 2024 Outlook [BNN Bloomberg (Canada)]

ImmunoGen, Inc.  (IMGN) 
Last immunogen, inc. earnings: 5/1 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.immunogen.com/investor-relations
PDF Adjusted earnings for the year will be $11.05 to $11.25 a share, AbbVie said in a statement Friday, up from its earlier view of at least $11 a share. The outlook includ [Read more]